{"pmid":32320740,"title":"Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019.","text":["Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019.","BACKGROUND: The pandemic of coronavirus disease 2019 (COVID-19) has become a global threat to public health. The lipid pathophysiology in COVID-19 is unknown. METHODS: In this retrospective longitudinal study, we monitored the serum lipids in 17 surviving and 4 non-surviving COVID-19 cases prior to their viral infections and duration the entire disease courses. RESULTS: In surviving cases, the low-density lipoprotein (LDL) levels decreased significantly on admission as compared with the levels before infection; the LDL levels remained constantly low during the disease progression and resumed to the original levels when patients recovered (pre-infection: 3.5 (3.0-4.4); on admission: 2.8 (2.3-3.1), p<.01; progression: 2.5 (2.3-3.0); discharge: 3.6 (2.7-4.1); median (IQR), in mmol/L). In non-surviving patients, LDL levels showed an irreversible and continuous decrease until death (1.1 (0.9-1.2), p=.02 versus the levels on admission). The ratio changes of LDL levels inversely correlated with ratio changes of high-sensitivity C-reactive protein levels. Logistic regression analysis showed increasing odds of lowered LDL levels associated with disease progression (odds ratio: 4.48, 95% IC: 1.55-12.92, p=.006) and in-hospital death (odds ratio: 21.72, 95% IC: 1.40-337.54, p=.028). CONCLUSIONS: LDL levels inversely correlated to disease severities, which could be a predictor for disease progress and poor prognosis.","Metabolism","Fan, Junli","Wang, Hui","Ye, Guangming","Cao, Xiaoling","Xu, Xianqun","Tan, Wenbin","Zhang, Yongxi","32320740"],"abstract":["BACKGROUND: The pandemic of coronavirus disease 2019 (COVID-19) has become a global threat to public health. The lipid pathophysiology in COVID-19 is unknown. METHODS: In this retrospective longitudinal study, we monitored the serum lipids in 17 surviving and 4 non-surviving COVID-19 cases prior to their viral infections and duration the entire disease courses. RESULTS: In surviving cases, the low-density lipoprotein (LDL) levels decreased significantly on admission as compared with the levels before infection; the LDL levels remained constantly low during the disease progression and resumed to the original levels when patients recovered (pre-infection: 3.5 (3.0-4.4); on admission: 2.8 (2.3-3.1), p<.01; progression: 2.5 (2.3-3.0); discharge: 3.6 (2.7-4.1); median (IQR), in mmol/L). In non-surviving patients, LDL levels showed an irreversible and continuous decrease until death (1.1 (0.9-1.2), p=.02 versus the levels on admission). The ratio changes of LDL levels inversely correlated with ratio changes of high-sensitivity C-reactive protein levels. Logistic regression analysis showed increasing odds of lowered LDL levels associated with disease progression (odds ratio: 4.48, 95% IC: 1.55-12.92, p=.006) and in-hospital death (odds ratio: 21.72, 95% IC: 1.40-337.54, p=.028). CONCLUSIONS: LDL levels inversely correlated to disease severities, which could be a predictor for disease progress and poor prognosis."],"journal":"Metabolism","authors":["Fan, Junli","Wang, Hui","Ye, Guangming","Cao, Xiaoling","Xu, Xianqun","Tan, Wenbin","Zhang, Yongxi"],"date":"2020-04-23T11:00:00Z","year":2020,"_id":"32320740","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.metabol.2020.154243","keywords":["covid-19","ldl","lipid","odds ratio"],"source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1664815087845638144,"score":8.518259,"similar":[{"pmid":32294485,"pmcid":"PMC7152876","title":"Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan.","text":["Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan.","BACKGROUND: In December 2019, COVID-19 outbreak occurred in Wuhan. Data on the clinical characteristics and outcomes of patients with severe COVID-19 are limited. OBJECTIVE: The severity on admission, complications, treatment, and outcomes of COVID-19 patients were evaluated. METHODS: Patients with COVID-19 admitted to Tongji Hospital from January 26, 2020 to February 5, 2020 were retrospectively enrolled and followed-up until March 3, 2020. Potential risk factors for severe COVID-19 were analyzed by a multivariable binary logistic model. Cox proportional hazard regression model was used for survival analysis in severe patients. RESULTS: We identified 269 (49.1%) of 548 patients as severe cases on admission. Elder age, underlying hypertension, high cytokine levels (IL-2R, IL-6, IL-10, and TNF-a), and high LDH level were significantly associated with severe COVID-19 on admission. The prevalence of asthma in COVID-19 patients was 0.9%, markedly lower than that in the adult population of Wuhan. The estimated mortality was 1.1% in nonsevere patients and 32.5% in severe cases during the average 32 days of follow-up period. Survival analysis revealed that male, elder age, leukocytosis, high LDH level, cardiac injury, hyperglycemia, and high-dose corticosteroid use were associated with death in patients with severe COVID-19. CONCLUSIONS: Patients with elder age, hypertension, and high LDH level need careful observation and early intervention to prevent the potential development of severe COVID-19. Severe male patients with heart injury, hyperglycemia, and high-dose corticosteroid use may have high risk of death.","J Allergy Clin Immunol","Li, Xiaochen","Xu, Shuyun","Yu, Muqing","Wang, Ke","Tao, Yu","Zhou, Ying","Shi, Jing","Zhou, Min","Wu, Bo","Yang, Zhenyu","Zhang, Cong","Yue, Junqing","Zhang, Zhiguo","Renz, Harald","Liu, Xiansheng","Xie, Jungang","Xie, Min","Zhao, Jianping","32294485"],"abstract":["BACKGROUND: In December 2019, COVID-19 outbreak occurred in Wuhan. Data on the clinical characteristics and outcomes of patients with severe COVID-19 are limited. OBJECTIVE: The severity on admission, complications, treatment, and outcomes of COVID-19 patients were evaluated. METHODS: Patients with COVID-19 admitted to Tongji Hospital from January 26, 2020 to February 5, 2020 were retrospectively enrolled and followed-up until March 3, 2020. Potential risk factors for severe COVID-19 were analyzed by a multivariable binary logistic model. Cox proportional hazard regression model was used for survival analysis in severe patients. RESULTS: We identified 269 (49.1%) of 548 patients as severe cases on admission. Elder age, underlying hypertension, high cytokine levels (IL-2R, IL-6, IL-10, and TNF-a), and high LDH level were significantly associated with severe COVID-19 on admission. The prevalence of asthma in COVID-19 patients was 0.9%, markedly lower than that in the adult population of Wuhan. The estimated mortality was 1.1% in nonsevere patients and 32.5% in severe cases during the average 32 days of follow-up period. Survival analysis revealed that male, elder age, leukocytosis, high LDH level, cardiac injury, hyperglycemia, and high-dose corticosteroid use were associated with death in patients with severe COVID-19. CONCLUSIONS: Patients with elder age, hypertension, and high LDH level need careful observation and early intervention to prevent the potential development of severe COVID-19. Severe male patients with heart injury, hyperglycemia, and high-dose corticosteroid use may have high risk of death."],"journal":"J Allergy Clin Immunol","authors":["Li, Xiaochen","Xu, Shuyun","Yu, Muqing","Wang, Ke","Tao, Yu","Zhou, Ying","Shi, Jing","Zhou, Min","Wu, Bo","Yang, Zhenyu","Zhang, Cong","Yue, Junqing","Zhang, Zhiguo","Renz, Harald","Liu, Xiansheng","Xie, Jungang","Xie, Min","Zhao, Jianping"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32294485","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.jaci.2020.04.006","keywords":["covid-19","mortality","risk factor","sars-cov-2","severity"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"locations":["Wuhan","Wuhan","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664636192688177154,"score":169.11961},{"pmid":32318325,"pmcid":"PMC7171052","title":"The clinical data from 19 critically ill patients with coronavirus disease 2019: a single-centered, retrospective, observational study.","text":["The clinical data from 19 critically ill patients with coronavirus disease 2019: a single-centered, retrospective, observational study.","Background: The objectives of this study were to analyze the clinical features of coronavirus disease 2019 (COVID-19) and evaluate the diagnosis and treatment. Methods: A retrospective analysis of the clinical manifestation and auxiliary examination of 19 patients with COVID-19 from the Liyuan Hospital intensive care unit (ICU) between January 16, 2020 and February 20, 2020 was undertaken. Results: There were 11 male and 8 female cases among the patients. The median (range) age was 73 (38-91) years. Of these patients, 8 (42.1%) had died and the median duration from ICU admission to death was 2 (interquartile range (IQR): 1-10.75) days. Seven of these 8 patients had underlying diseases. The auxiliary examination showed fever (68.4%), dry cough (15.8%), dyspnea (10.5%), and diarrhea (5.3%). All 19 cases showed ground-glass changes on chest computed tomography. Serum hypersensitive C-reactive protein (hs-CRP) and serum amylase A (SAA) were clearly increased in all of the cases. Among the 19 cases, there were 16 (84.2%) cases in which the total number of lymphocytes decreased, 12 cases (63%) had reduced liver function, and 11 cases (58%) had deviant results for fibrinogen (FIB) and D-dimer, in particular, the D-dimer level was significantly higher in the non-survivors compared with the survivors. Conclusion: There were more men than women among critically ill patients. All of the cases showed ground-glass changes on chest computed tomography and the vast majority of patients displayed fever and dry cough. The clinical laboratory indices change significantly, especially the D-dimer level among non-survivors.","Z Gesundh Wiss","Zhang, Jinping","Liu, Peng","Wang, Morong","Wang, Jie","Chen, Jie","Yuan, Wenling","Li, Mei","Xie, Zhijuan","Dong, Wangping","Li, Hongye","Zhao, Yan","Wan, Lun","Chu, Tian","Wang, Lu","Zhang, Hui","Tao, Ting","Ma, Jing","32318325"],"abstract":["Background: The objectives of this study were to analyze the clinical features of coronavirus disease 2019 (COVID-19) and evaluate the diagnosis and treatment. Methods: A retrospective analysis of the clinical manifestation and auxiliary examination of 19 patients with COVID-19 from the Liyuan Hospital intensive care unit (ICU) between January 16, 2020 and February 20, 2020 was undertaken. Results: There were 11 male and 8 female cases among the patients. The median (range) age was 73 (38-91) years. Of these patients, 8 (42.1%) had died and the median duration from ICU admission to death was 2 (interquartile range (IQR): 1-10.75) days. Seven of these 8 patients had underlying diseases. The auxiliary examination showed fever (68.4%), dry cough (15.8%), dyspnea (10.5%), and diarrhea (5.3%). All 19 cases showed ground-glass changes on chest computed tomography. Serum hypersensitive C-reactive protein (hs-CRP) and serum amylase A (SAA) were clearly increased in all of the cases. Among the 19 cases, there were 16 (84.2%) cases in which the total number of lymphocytes decreased, 12 cases (63%) had reduced liver function, and 11 cases (58%) had deviant results for fibrinogen (FIB) and D-dimer, in particular, the D-dimer level was significantly higher in the non-survivors compared with the survivors. Conclusion: There were more men than women among critically ill patients. All of the cases showed ground-glass changes on chest computed tomography and the vast majority of patients displayed fever and dry cough. The clinical laboratory indices change significantly, especially the D-dimer level among non-survivors."],"journal":"Z Gesundh Wiss","authors":["Zhang, Jinping","Liu, Peng","Wang, Morong","Wang, Jie","Chen, Jie","Yuan, Wenling","Li, Mei","Xie, Zhijuan","Dong, Wangping","Li, Hongye","Zhao, Yan","Wan, Lun","Chu, Tian","Wang, Lu","Zhang, Hui","Tao, Ting","Ma, Jing"],"date":"2020-04-23T11:00:00Z","year":2020,"_id":"32318325","week":"202017|Apr 20 - Apr 26","doi":"10.1007/s10389-020-01291-2","keywords":["clinical manifestations","coronavirus disease 2019","d-dimer","epidemiology","retrospective"],"source":"PubMed","topics":["Diagnosis","Treatment"],"weight":1,"_version_":1664815087813132288,"score":162.43385},{"pmid":32277967,"pmcid":"PMC7141628","title":"Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis.","text":["Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis.","BACKGROUND: To explore the significance of SAA in evaluating the severity and prognosis of COVID-19. METHODS: A total of 132 patients with confirmed COVID-19 who were admitted to a designated COVID-19 hospital in Wuhan, China from January 18, 2020 to February 26, 2020 were collected. The dynamic changes of blood SAA, CRP, PCT, WBC, Lymphocyte (L), PLT, CT imaging, and disease progression were studied. All patients completed at least twice laboratory data collection and clinical condition assessment at three time points indicated for this study; The length of hospital stay was longer than 14 days prior to February 26, 2020. RESULTS: COVID-19 patients had significantly increased SAA and CRP levels, while L count decreased, and PCT, WBC, and PLT were in the normal range. As disease progressed from mild to critically severe, SAA and CRP gradually increased, while L decreased, and PLT, WBC, and PCT had no significant changes; ROC curve analysis suggests that SAA/L, CRP, SAA, and L count are valuable in evaluating the severity of COVID-19 and distinguishing critically ill patients from mild ones; Patients with SAA consistently trending down during the course of disease have better prognosis, compared with the patients with SAA continuously rising; The initial SAA level is positively correlated with the dynamic changes of the serial CT scans. Patient with higher initial SAA level are more likely to have poor CT imaging. CONCLUSIONS: SAA and L are sensitive indicators in evaluating the severity and prognosis of COVID-19. Monitoring dynamic changes of SAA, combined with CT imaging could be valuable in diagnosis and treatment of COVID-19.","J Infect","Li, Huan","Xiang, Xiaochen","Ren, Hongwei","Xu, Lingli","Zhao, Lisha","Chen, Xiaoqiong","Long, Hui","Wang, Qiang","Wu, Qingming","32277967"],"abstract":["BACKGROUND: To explore the significance of SAA in evaluating the severity and prognosis of COVID-19. METHODS: A total of 132 patients with confirmed COVID-19 who were admitted to a designated COVID-19 hospital in Wuhan, China from January 18, 2020 to February 26, 2020 were collected. The dynamic changes of blood SAA, CRP, PCT, WBC, Lymphocyte (L), PLT, CT imaging, and disease progression were studied. All patients completed at least twice laboratory data collection and clinical condition assessment at three time points indicated for this study; The length of hospital stay was longer than 14 days prior to February 26, 2020. RESULTS: COVID-19 patients had significantly increased SAA and CRP levels, while L count decreased, and PCT, WBC, and PLT were in the normal range. As disease progressed from mild to critically severe, SAA and CRP gradually increased, while L decreased, and PLT, WBC, and PCT had no significant changes; ROC curve analysis suggests that SAA/L, CRP, SAA, and L count are valuable in evaluating the severity of COVID-19 and distinguishing critically ill patients from mild ones; Patients with SAA consistently trending down during the course of disease have better prognosis, compared with the patients with SAA continuously rising; The initial SAA level is positively correlated with the dynamic changes of the serial CT scans. Patient with higher initial SAA level are more likely to have poor CT imaging. CONCLUSIONS: SAA and L are sensitive indicators in evaluating the severity and prognosis of COVID-19. Monitoring dynamic changes of SAA, combined with CT imaging could be valuable in diagnosis and treatment of COVID-19."],"journal":"J Infect","authors":["Li, Huan","Xiang, Xiaochen","Ren, Hongwei","Xu, Lingli","Zhao, Lisha","Chen, Xiaoqiong","Long, Hui","Wang, Qiang","Wu, Qingming"],"date":"2020-04-12T11:00:00Z","year":2020,"_id":"32277967","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.jinf.2020.03.035","keywords":["c-reactive protein","computed tomography imaging","coronavirus disease 2019","lymphocyte","serum amyloid a","severity"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664636943954083842,"score":156.86906},{"pmid":32283877,"title":"[Prognostic value of myocardial injury in patients with COVID-19].","text":["[Prognostic value of myocardial injury in patients with COVID-19].","Objective: To analyze the prognostic value of myocardial injury in patients with COVID-19. Method: Confirmed cases of COVID-19 patients admitted from January 31st to February 5th at isolation ward of Renmin Hospital of Wuhan University were divided into non-survival group and survival group according to the clinical outcomes 5 weeks after admission. Data including demographics, comorbidities, vital signs, laboratory results were obtained. Cardiac injury was defined as serum concentration of high sensitivity cardiac troponin I (hs-cTnI) above 0.04 mug/L. Univariate and multivariate Cox regression were used to analyze the prognostic value of myocardial injury in patients with COVID-19. Kaplan-Meier analysis was used to plotted survival curve and analyze the impact of myocardial injury on the survival outcome of COVID-19 patients. Results: A total of 202 patients were included, the age was 63 (51, 70) years old, 88 (43.6%) of them were male, 85 (42.1%) of them had comorbidities, 125 (61.9%) of them were severely to critically ill. Till March 11, 33 patients died, all of them were critically ill patients. The age, proportion of males, comorbidities, respire rate, serum levels of hs-cTnI and incidence of heart failure in the non-survival group were significantly higher than those in the survival group (all P<0.05). The hospitalization time of non-survival group was significantly shorter than that of survival group (6(4, 9) vs. 32(23, 36), P<0.001). Myocardial injury was an important prognostic factor of COVID-19 (HR=5.382, 95%CI 2.404-12.05, P<0.001). Kaplan-Meier survival analysis showed that the presence of myocardial injury was significantly associated with the reduced survival rate among COVID-19 patients (P<0.001). Conclusion: Myocardial injury is an important prognostic factor of COVID-19, COVID-19 patients with myocardial injury face a significantly higher risk of death.","Zhonghua Yan Ke Za Zhi","Wang, L","He, W B","Yu, X M","Liu, H F","Zhou, W J","Jiang, H","32283877"],"abstract":["Objective: To analyze the prognostic value of myocardial injury in patients with COVID-19. Method: Confirmed cases of COVID-19 patients admitted from January 31st to February 5th at isolation ward of Renmin Hospital of Wuhan University were divided into non-survival group and survival group according to the clinical outcomes 5 weeks after admission. Data including demographics, comorbidities, vital signs, laboratory results were obtained. Cardiac injury was defined as serum concentration of high sensitivity cardiac troponin I (hs-cTnI) above 0.04 mug/L. Univariate and multivariate Cox regression were used to analyze the prognostic value of myocardial injury in patients with COVID-19. Kaplan-Meier analysis was used to plotted survival curve and analyze the impact of myocardial injury on the survival outcome of COVID-19 patients. Results: A total of 202 patients were included, the age was 63 (51, 70) years old, 88 (43.6%) of them were male, 85 (42.1%) of them had comorbidities, 125 (61.9%) of them were severely to critically ill. Till March 11, 33 patients died, all of them were critically ill patients. The age, proportion of males, comorbidities, respire rate, serum levels of hs-cTnI and incidence of heart failure in the non-survival group were significantly higher than those in the survival group (all P<0.05). The hospitalization time of non-survival group was significantly shorter than that of survival group (6(4, 9) vs. 32(23, 36), P<0.001). Myocardial injury was an important prognostic factor of COVID-19 (HR=5.382, 95%CI 2.404-12.05, P<0.001). Kaplan-Meier survival analysis showed that the presence of myocardial injury was significantly associated with the reduced survival rate among COVID-19 patients (P<0.001). Conclusion: Myocardial injury is an important prognostic factor of COVID-19, COVID-19 patients with myocardial injury face a significantly higher risk of death."],"journal":"Zhonghua Yan Ke Za Zhi","authors":["Wang, L","He, W B","Yu, X M","Liu, H F","Zhou, W J","Jiang, H"],"date":"2020-04-15T11:00:00Z","year":2020,"_id":"32283877","week":"202016|Apr 13 - Apr 19","doi":"10.3760/cma.j.cn112148-20200313-00202","keywords":["covid-19","cardiac insufficiency","cardiac troponin","myocardial injury","prognosis"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"_version_":1664636391712096257,"score":150.2724},{"pmid":32334115,"title":"Preliminary estimating the reproduction number of the coronavirus disease (COVID-19) outbreak in Republic of Korea and Italy by 5 March 2020.","text":["Preliminary estimating the reproduction number of the coronavirus disease (COVID-19) outbreak in Republic of Korea and Italy by 5 March 2020.","The novel coronavirus disease 2019 (COVID-19) outbreak and Italy has caused 6088 cases and 41 deaths in Republic of Korea and 3144 cases and 107 death in Italy by 5 March 2020. We modeled the transmission process in Republic of Korea and Italy with a stochastic model and estimated the basic reproduction number R0 as 2.6 (95% CI: 2.3-2.9) or 3.2 (95% CI: 2.9-3.5) in Republic of Korea, under the assumption that the exponential growth starting on 31 January or 5 February 2020, and 2.6 (95% CI: 2.3-2.9) or 3.3 (95% CI: 3.0-3.6) in Italy, under the assumption that the exponential growth starting on 5 February or 10 February 2020.","Int J Infect Dis","Zhuang, Zian","Zhao, Shi","Lin, Qianying","Cao, Peihua","Lou, Yijun","Yang, Lin","Yang, Shu","He, Daihai","Xiao, Li","32334115"],"abstract":["The novel coronavirus disease 2019 (COVID-19) outbreak and Italy has caused 6088 cases and 41 deaths in Republic of Korea and 3144 cases and 107 death in Italy by 5 March 2020. We modeled the transmission process in Republic of Korea and Italy with a stochastic model and estimated the basic reproduction number R0 as 2.6 (95% CI: 2.3-2.9) or 3.2 (95% CI: 2.9-3.5) in Republic of Korea, under the assumption that the exponential growth starting on 31 January or 5 February 2020, and 2.6 (95% CI: 2.3-2.9) or 3.3 (95% CI: 3.0-3.6) in Italy, under the assumption that the exponential growth starting on 5 February or 10 February 2020."],"journal":"Int J Infect Dis","authors":["Zhuang, Zian","Zhao, Shi","Lin, Qianying","Cao, Peihua","Lou, Yijun","Yang, Lin","Yang, Shu","He, Daihai","Xiao, Li"],"date":"2020-04-26T11:00:00Z","year":2020,"_id":"32334115","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.ijid.2020.04.044","keywords":["coronavirus disease 2019","italy","republic of korea","the basic reproduction number"],"source":"PubMed","topics":["Epidemic Forecasting"],"weight":1,"locations":["Italy","South Korea","Italy","South Korea","Italy","South Korea","Italy","South Korea","Italy"],"countries":["Korea, Republic of","Italy"],"countries_codes":["KOR|Korea, Republic of","ITA|Italy"],"_version_":1665071049670131713,"score":146.79669}]}